Publications by authors named "Toyooka S"

Brain metastasis (BM) is a poor prognostic factor in cancer patients. Despite showing efficacy in many extracranial tumors, immunotherapy with anti-PD-1 monoclonal antibody (mAb) or anti-CTLA-4 mAb appears to be less effective against intracranial tumors. Promisingly, recent clinical studies have reported that combination therapy with anti-PD-1 and anti-CTLA-4 mAbs has a potent antitumor effect on BM, highlighting the need to elucidate the detailed mechanisms controlling the intracranial tumor microenvironment (TME) to develop effective immunotherapeutic strategies.

View Article and Find Full Text PDF

Background: Lung cancer with interstitial pneumonia is known to be a refractory disease. We explored whether systemic inflammatory response markers are associated with outcomes in these patients.

Methods: The participants of this multicenter retrospective study, consisting of 17 medical institutions, were treatment-naïve patients with lung cancer combined with interstitial pneumonia who underwent surgical resection between 2012 and 2017.

View Article and Find Full Text PDF

Although the prognosis of breast cancer has significantly improved compared to other types of cancer, there are still some patients who expire due to recurrence or metastasis. Therefore, it is necessary to develop a method to identify patients with poor prognosis at the early stages of cancer. In the process of discovering new prognostic markers from genes of unknown function, we found that the expression of C1orf50 determines the prognosis of breast cancer patients, especially for those with Luminal A breast cancer.

View Article and Find Full Text PDF

Purpose: It is not known where the anatomical axis of rotation on the tibial side will be in kinematic alignment (KA), a rapidly expanding area of total knee arthroplasty (TKA) alignment technique today. The purpose of this study was to define the tibial axis for KA-TKA.

Methods: Fifty patients who underwent computed tomography (CT) examination of the lower extremities at a single institution were included.

View Article and Find Full Text PDF

SPRED2 (Sprouty-related, EVH1 domain-containing protein 2), a negative regulator of the ERK1/2 pathway, is downregulated in several cancers; however, the significance of SPRED2 expression in lung adenocarcinoma (LUAD) remains unclear. Here, we investigated the pathological expression of SPRED2 and its relationship with ERK1/2 activation (ERK1/2 phosphorylation), Ki67 index and clinicopathological features in 77 LUAD tissues from clinical patients. Immunohistochemically, SPRED2 expression was decreased in invasive adenocarcinoma (IA) compared to adenocarcinoma in situ (AIS).

View Article and Find Full Text PDF
Article Synopsis
  • The first-generation vector pCMViR-TSC shows significantly higher gene expression (10- to 100-fold) compared to standard plasmids but is limited to transient gene expression in mammalian cells.
  • To address this limitation, a new second-generation vector, pSAKA-4B, is introduced, enabling stable integration of genes into mammalian DNA with high efficiency.
  • This improved vector system allows for indefinite gene expression, making it valuable for basic research and potential clinical applications like gene therapy.
View Article and Find Full Text PDF

Background: Surgical resection followed by adjuvant chemotherapy is currently the first choice for the treatment of clinical N1 (cN1) non-small cell lung cancer (NSCLC). However, diagnosing cN1 correctly can be difficult, even with current imaging diagnostic technologies. We aimed to analyze the diagnostic accuracy of preoperative nodal status and the predictive factors for nodal upstaging of cN1-NSCLC.

View Article and Find Full Text PDF

Background: Management of tacrolimus trough levels (TTLs) influences morbidity and mortality after lung transplantation. Several studies have explored pharmacokinetic and artificial intelligence models to monitor tacrolimus levels. However, many models depend on a wide range of variables, some of which, like genetic polymorphisms, are not commonly tested for in regular clinical practice.

View Article and Find Full Text PDF

Background: Despite the global use of trastuzumab biosimilars, concerns remain regarding their efficacy and safety. In particular, when used concurrently with pertuzumab, trastuzumab biosimilars lack extensive real-world data and safety information. Additionally, as cancer drug expenditures continue to rise worldwide, cost savings from biosimilars have become increasingly important.

View Article and Find Full Text PDF
Article Synopsis
  • Ischemia-reperfusion injury (IRI) can cause problems for lung transplants, especially when the lungs come from donors who have died from heart issues.
  • The research focused on a gene called NR4A1 to see how it affects IRI and lung function during transplants.
  • Results showed that lungs from donors with higher NR4A1 levels had better function and less cell damage after transplants, suggesting targeting NR4A1 could help improve transplant success.
View Article and Find Full Text PDF

Imatinib may be a useful targeted agent for patients with advanced gastric adenocarcinoma who have KIT mutations.

View Article and Find Full Text PDF

A 55-year-old man presented to our hospital with idiopathic pulmonary fibrosis (IPF). He was registered with the Japan Organ Transplant Network the following year due to disease progression. Treatment with clarithromycin, ethambutol, and rifampicin for complications of Mycobacterium avium pulmonary disease was initiated, but sputum conversion could not be achieved.

View Article and Find Full Text PDF

Purpose: Bronchopleural fistula (BPF) is a serious complication of lung resection. To avoid BPF, the bronchial stump/anastomotic site is often covered with a flap of surrounding tissue. One risk factor for BPF is radical lung resection after induction chemoradiotherapy for lung cancer.

View Article and Find Full Text PDF

Immune checkpoint inhibitors (ICIs) exert clinical efficacy against various types of cancers by reinvigorating exhausted CD8 T cells that can expand and directly attack cancer cells (cancer-specific T cells) among tumor-infiltrating lymphocytes (TILs). Although some reports have identified somatic mutations in TILs, their effect on antitumor immunity remains unclear. In this study, we successfully established 18 cancer-specific T cell clones, which have an exhaustion phenotype, from the TILs of four patients with melanoma.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined how oxidative stress relates to blood amino acids involved in nitric oxide metabolism in 100 hospitalized COVID-19 pneumonia patients, analyzing their clinical data and serum samples from July 2020 to August 2021.
  • - Patients needing oxygen therapy had higher hydroperoxide levels and lower citrulline levels than the control group, while no significant differences were found in other related compounds like nitrite/nitrate.
  • - The findings indicated a connection between increased oxidative stress, reduced citrulline levels, and more severe pneumonia, suggesting that these factors might contribute to the development of COVID-19 pneumonia.
View Article and Find Full Text PDF

Background: Induction therapy followed by surgery is recommended as an alternative treatment strategy for locally advanced non-small cell lung cancer (NSCLC). Patients who achieve pathologic response after induction therapy have better outcomes than non-responders; therefore, therapeutic response must be evaluated. Recently, new approaches for monitoring therapeutic responses, which are based on F-Fluorodeoxyglucose positron emission tomography (FDG-PET), have been developed.

View Article and Find Full Text PDF

Background: Sarcomatoid carcinoma of the lung is a rare histological type of non-small cell lung cancer with a poor prognosis. We aimed to investigate the clinicopathological characteristics and prognostic factors of surgically resected sarcomatoid carcinoma of the lung.

Methods: We retrospectively reviewed 14999 patients who underwent surgical resection for non-small cell lung cancer accumulated by the Japanese Joint Committee of Lung Cancer Registry in 2010.

View Article and Find Full Text PDF

Background: Since lung transplant recipients (LTRs) exhibit low immunogenicity after two doses of SARS-CoV-2 mRNA vaccines, optimal vaccine strategies for SARS-CoV-2 are required in LTRs. This study aimed to investigate the efficacy and safety of the third and fourth doses of the SARS-CoV-2 mRNA vaccines in LTRs.

Methods: We conducted a single-center study of 73 LTRs and 23 healthy controls (HCs).

View Article and Find Full Text PDF

Background: Although the association between higher physical activity and preventive effect on breast-cancer-related lymphoedema (BCRL) has been reported, it is unclear what intervention is optimal. We aimed to investigate the effect of exercise and educational programs on BCRL development.

Methods: This study was a secondary endpoint analysis from a prospective randomized controlled trial.

View Article and Find Full Text PDF
Article Synopsis
  • There is ongoing debate on whether mechanical alignment (MA) or kinematic alignment (KA) is better for total knee arthroplasty (TKA) in patients with specific knee alignment issues.
  • A study involving 64 patients compared the two alignment methods to see which provided better soft tissue balance after TKA, using advanced optical tracking technology.
  • Results showed that the KA group had significantly better soft tissue balance in extension and a higher overall balance rate (75%) compared to the MA group (38%), suggesting that KA is more effective for this patient population.
View Article and Find Full Text PDF

Purpose: Various studies have demonstrated the causal relationship between gut microbiota and efficacy of chemotherapy; however, the impact of gut microbiota on breast cancer has not been fully elucidated. This study aimed to evaluate the associations between the gut microbiota before neoadjuvant chemotherapy and its consequent efficacy in breast cancer.

Methods: This prospective observational study included patients who received neoadjuvant chemotherapy for primary early breast cancer at eight institutions between October 1, 2019, and March 31, 2022.

View Article and Find Full Text PDF

Background: Triple-negative breast cancer (TNBC) cells are a highly formidable cancer to treat. Nonetheless, by continued investigation into the molecular biology underlying the complex regulation of TNBC cell activity, vulnerabilities can be exposed as potential therapeutic targets at the molecular level. We previously revealed that lysyl oxidase-like 4 (LOXL4) promotes the invasiveness of TNBC cells via cell surface annexin A2 as a novel binding substrate of LOXL4, which promotes the abundant localization of integrin-β1 at the cancer plasma membrane.

View Article and Find Full Text PDF
Article Synopsis
  • This study examines the effects of perioperative therapies on treatment outcomes for Japanese patients with clinical stage III non-small cell lung cancer (NSCLC), analyzing data from the SOLUTION study involving 149 patients who started treatment between 2013-2014.
  • Results showed that patients who received surgery combined with perioperative therapy had significantly better overall survival (29.3 months vs. not reached) and 3-year survival rates (44.0% vs. 61.1%) compared to those who had surgery alone.
  • The analysis indicates that perioperative therapy is linked to improved overall survival, progression-free survival, and disease-free survival, suggesting its importance in enhancing treatment outcomes for NSCLC patients
View Article and Find Full Text PDF

Double-lung transplantation (DLT) is favored for enhanced long-term survival despite the risk of major complications, particularly in elderly patients or those with comorbidities. Two-stage contralateral single-lung transplantation (SLT) leading to DLT is considered a valuable option to combine the advantages of less invasive SLT with DLT survival benefits. This study detailed the intraoperative challenges encountered during the procedure.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on understanding how lung cancer cells develop resistance to crizotinib, a MET tyrosine kinase inhibitor, particularly in cases of MET amplification.
  • Researchers established two MET-amplified lung cancer cell lines, EBC-1 and H1993, to explore the mechanisms behind this acquired resistance, using genomic and transcriptomic data for analysis.
  • Findings revealed various resistance mechanisms, including SERPINE1 overexpression in EBC-1 cells and potential therapies like PAI-1 inhibitors or MEK inhibitors for overcoming resistance in these cancer cells.
View Article and Find Full Text PDF